Understanding the Current Site Sector Consolidation Trend

About our in-house industry expert, Barry Lake, Co-Founder and President of Devana Solutions: Before co-founding Devana Solutions, Barry Lake gained hands-on experience in site operations at a clinical research site in Charleston, South Carolina. In addition to managing his own site, he was part of a management team that established an early “network” of high-performing, independent yet affiliated sites that shared marketing and sales resources. He witnessed the emergence of strategic acquisitions and site consolidations, notably in 2015 when PPD acquired Synexus’s approximately 100+ sites and ICON acquired PMG Research’s 12 U.S. sites. In 2019, ICON further expanded by combining PMG’s U.S. footprint with MeDiNova’s European sites, forming the Accellacare Global Site Network, now comprising approximately 112 sites. 

The clinical research industry is undergoing a profound transformation, driven by market consolidation and technological innovation. To adapt, clinical research sites are embracing innovation, increased collaboration, and strategic positioning to thrive. The site consolidation trend shows no sign of abating. In this blog post, we caught up with Barry Lake, co-founder at Devana Solutions, a RealTime Software Solutions Company. We wanted to better understand the driving forces behind the site consolidation trend and uncover key investment areas for sites aspiring to accelerate their growth and enhance their appeal to sponsors and investors. 

Interview with Barry Lake

Q: Can you share your background and how it influenced your journey in the clinical trials industry? 

Barry Lake: Before co-founding Devana Solutions, I gained experience in site operations at a clinical research site in Charleston, South Carolina. This first-hand experience of the pain points of running a site, coupled with witnessing the emergence of strategic acquisitions and site consolidations, inspired me to pioneer the Devana Solution platform. Launched in 2016, Devana built a category-defining product that addresses the challenge with study start-up, pipeline management and business intelligence for sites, sponsors, and CROs. 

 

Q: Can you share your observations on the current trends shaping the clinical research landscape, particularly regarding site success and market consolidation? 

Barry Lake: Absolutely. We have been witnessing a significant shift in the clinical research industry, characterized by the consolidation of site networks. Strategic acquisitions and private equity investments are driving this trend, leading to the emergence of larger, integrated site networks. This consolidation presents both opportunities and challenges for sites as they maneuver through the complexities of modern clinical trials.  

Organizations transitioning from “boutique” businesses to sustainable enterprises are leveraging capital to increase their scale and value. Successful execution necessitates securing sufficient capital to sustain competitive advantage and drive growth. In the site sector consolidation, winners emerge by executing profitably and strategically accessing capital. 

If an organization makes the commitment to move beyond being a boutique business towards building truly sustainable enterprise value through a leading position therapeutically or through scale across a geographic footprint, over time, the leadership will face relentless and ever-increasing pressures stemming from their own commercial success. The good news for these site organizations is they will certainly be much more valuable in private equity’s eyes, assuming their leadership is open to leveraging more capital to increase their scale. Successful execution inevitably requires increasingly larger tranches of capital for any organization to sustain a balance sheet that enables them to maintain a competitive advantage and continue scaling and increasing their enterprise value over the long term.  

In other words, when an industry sector consolidates fueled by the efficient deployment of a massive amount of capital at scale (the role of the financial sector in every industry) it envelopes both types of companies in the sector: the losers and the winners. The losers in the clinical trial site sector will be those site organizations that cannot evolve into a becoming one of leaders either by not performing profitably or, if they do, in fact, become profitable their ownership fails to seek sufficient capital to shore up their balance sheet and drive their growing dominance.  

I foresee that those organizations that fail to access more capital when they need it will be outmaneuvered over the long run by more savvy competitors with stronger balance sheets. As a result, the site organizations on the wrong side of market forces will either go out of business if they are unprofitable or, if they don’t seek more capital to shore up their balance sheet, be forced to eventually sell at a depressed value to a competitor or industry aggregators. 

The ultimate winners in this consolidation battle will be those site organizations who execute profitably and then attract and, are willing to accept, additional capital on reasonable terms at numerous inflection points along their growth journey. 

 

Q: How does essential site-based technology contribute to site success in this site consolidation market? 

Barry Lake: Technology can be a game-changer for clinical research sites looking to succeed in today’s competitive environment. Electronic solutions that replace error-prone paper-based processes, like Devana, enhance transparency, streamline workflows, and facilitate integration with the industry’s top CTMS providers including RealTime, CRIO and Clinical Conductor. Devana improves site business operations, accelerates study startup processes, and fosters efficiency across the entire clinical trial journey, from study start-up, execution to closeout. By leveraging advanced eClinical technology, sites can improve data accuracy, accountability, and position themselves as leaders within larger site networks. 

 

Q: What are some key strategies that clinical research sites can employ to capitalize on growth opportunities? 

Barry Lake: Strategic positioning is essential for clinical research sites. By focusing on areas of expertise, building strong relationships with sponsors and CROs, and investing in eClinical technology solutions built for clinical trials, sites can enhance their value proposition and attract increased investments. Additionally, collaboration and networking within larger site networks can open doors to new opportunities for growth and expansion. 

 

Q: What role does Devana play in shaping the future of clinical trials? 

Barry Lake: The private equity fueled site sector consolidation has continued to accelerate at a rapid pace heading in 2024 and Devana remains at the forefront of innovative eClinical solutions purpose-built to help sites scale faster. Devana delivers crucial transparency to site leadership and operating managers, shedding light on the upstream pipeline of trial opportunities and automating study startup workflows. In fact, on average, sites that have adopted Devana report 76% reduced contract budget and turnaround time, 14 hours saved in study activation, and 40% increased revenue. 

And the platform continues to shape the future of clinical trials through strategic partnerships like seamless integrations with industry-leading CTMS providers and cutting-edge new features such as our Query Feature, which allows central team members to query all sites within their network based on a given trial’s specific criteria for capabilities, equipment, and more. They can send new trial opportunities directly within PROPEL and receive real-time site responses and turnaround timing metrics in return. 

Today, we partner with many of the industry’s largest site networks to drive efficiency, compliance, and patient engagement. That’s why Devana is humbled to call virtually every major site network a partner-client. In fact, eight of the top 10 site networks in the world have already adopted Devana. The exponential growth of our site network clients spotlights the tangible benefits of leveraging advanced eClinical technology across the entire clinical trials journey.  

Final Thoughts

The momentum behind the site sector consolidation trend is undeniable and continues to gain traction. Whether it’s backing a single large site as a platform investment or spearheading a network roll-up strategy, private equity sponsors are actively seeking opportunities to deploy capital and drive site consolidation efforts.  

At RealTime Software Solutions, our team predicts that the consolidation trend will continue to play out similarly across the site sector as it did from the 1990’s through the early 2020’s in the CRO sector. The site consolidation wave will continue until the site space is largely dominated by only a handful of major global site organizations in much the same manner as just a handful of major global CROs control almost 80% of the pharmaceutical sponsors outsourcing spend on clinical trials that run through CROs. As such, it’s crucial for independent site owners to position themselves as market leaders in their respective fields, recognizing that acquisition by larger networks is inevitable for long-term success. By staying ahead of the curve and strategically investing in growth areas, sites can still emerge as industry leaders. 

Speed Up Your Research Site Organization’s Turnaround Times 

Regardless of size and type, clinical research site organizations compete for trial opportunities from CROs and sponsors. There are many factors that can make a site stand out amongst the crowd, but turnaround times for key items may be one of the larger deciding factors. CROs and sponsors want to get trials up and running as quickly as possible and demonstrating that your organization has a history of turning things around quickly can make you stand out.

Designed specifically for the clinical trial industry, PROPEL accelerates workflows and automatically captures and records turnaround timing and performance metrics along the way.

Accelerated Workflows 

Speed matters in clinical trials. That’s why PROPEL accelerates every step of the clinical trial process – from pipeline management to study startup and beyond. Optimize execution with standardized processes that offer full visibility into current and next steps across your organization, saving time and reducing the risk of things slipping through the cracks or getting delayed.  

Once a trial begins enrollment, it’s hard to speed things up. That’s why it’s important to accelerate those tasks which can be sped up, saving time and manpower for other critical areas of focus such as patient recruitment and enrollment. Designed to streamline every process possible, PROPEL eliminates many repetitive tasks, including data entry into a myriad of systems or sending countless emails to update sites. Instead, PROPEL’s seamless integrations allow you to enter data only once, while real-time collaboration tools foster easy communication with sites. Tracking trial milestones is also made easier, allowing sites and central teams alike to update progress, share key documents, and alert others to any roadblocks or questions.  

And, as trials move through the system, PROPEL automatically tracks turnaround times for activities such as business development, study startup, site-based milestones, and moreallowing you to see patterns and make informed decisions.  

Process and Performance Transparency 

PROPEL Site Activity Dashboard 

Data transparency is critical to effective clinical trial management. PROPEL was engineered with proprietary algorithms that automatically capture hundreds of process and performance metrics by indication, site, PI, trial, and more. In fact, every data point within PROPEL is reportable – allowing users to create custom dashboards and reports to analyze and share with key stakeholders.  

PROPEL’s cloud-based platform allows central teams to collaborate with site-based study teams in real time. Gain insight into your entire organization’s trial process and data from start to finish as it happens, allowing you to drive buy-in and accountability across the board. Effortlessly monitor the latest metrics on trial status, site activity, patient enrollment, and more – allowing central team members to take swift action based on the most up-to-date site activities and enrollment data, leading to faster decision-making and improved trial outcomes. This data can then improve the overall trial process by matching the right sites and investigators with the trials that best suit their capabilities and location. Once the proper teams are aligned, you’ll experience an increase in trial performance, reducing cycle times and allowing you to better predict future performance. 

Improve turnaround times and stand out to CROs and sponsors with PROPEL’s powerful workflow improvements and data analytics. Easily show both real-time and historic reports based on site activity, enrollment, indications, and more – helping win more trials that suit your organization’s strengths.  

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

Accelerate Study Cycle Times with Clinical Trial Software for CROs

In our post-pandemic world, contract research organizations (CROs) face more challenges than ever. With greater competition, market consolidation, and a growing emphasis on site empowerment, the CRO market is in a state of flux. Only those willing to be flexible as they apply learnings from the COVID-19 pandemic and its aftermath are likely to come out ahead.   

One of the key takeaways from the COVID-19 pandemic applied throughout the clinical trial industry is to invest in mission-critical technology. Devana Solutions’ category-defining PROPEL platform offers improved site selection, real-time communication, and site collaboration. PROPEL provides process and performance transparency while automating workflows, accelerating cycle times, and reducing the overall workload for CROs and sites. 

Improved Site Selection 

PROPEL Site Query Functionality

CROs have long relied on manual, time-consuming processes to identify the most suitable sites for new clinical trials. With PROPEL, we’ve eliminated this outdated approach. 

PROPEL enables CROs to perform targeted queries to determine suitable sites for new trials. Find the most effective sites in real-time by digitally querying site capabilities based on therapeutic expertise, physical site facilities, investigator and staff certifications, and more. PROPEL automatically stores site and investigator performance and capabilities data to share with sponsors or use for future trials.  

With PROPEL, CROs can be confident in the sites they’ve selected when reporting back to sponsors with progress updates. 

Real-Time Collaboration 

When you have a clinical trial underway, it’s important to have a tool that makes it easy for you to share information with sites—and receive real-time responses. 

Forget endless follow-up emails, calls, and meetings. Instead, push out mass communications or individually tag relevant users or site teams, alerting them of new trial opportunities, updates, or queries. PROPEL’s threaded chat conversations allow CROs and sites to pose questions, share documents, and provide updates. Real-time feedback from sites, such as if there are too many inclusion/exclusion criteria or more realistic estimates for patient enrollment, can help CROs with sponsor bid defenses. Sites can also ask questions and share documents via the same channels—keeping everyone in the loop throughout the entire clinical trial process.  

With PROPEL, CROs also gain insights into other site organizations already using PROPEL, including two of the largest site networks and the largest site organization in the world. 

Performance Transparency 

 

PROPEL Site Activity Dashboard

When running clinical trials, you need to be able to track and analyze current and historical metrics. This is where PROPEL comes in. 

Tracking current and historical trial metrics with PROPEL’s dashboards and reports can help CROs win more sponsor bid defenses by quantifying past successes and showcasing real-time updates for trials currently running. Key data generated throughout the clinical trial process is automatically stored within PROPEL and can be accessed via custom reports and visualizations whenever needed. Know exactly how a trial progresses from site selection to completion with real-time data capture and analysis. Identify bottlenecks in terms of site responses, patient enrollment, and more so you can step in and provide targeted support where needed.  

Sharing the latest data anytime with stakeholders and sponsors is critical to accelerating cycle times and mitigating bottlenecks and risks.  

Want to learn more? Download the PROPEL sell sheet 

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

Navigating the Great Resignation Within the Clinical Trial Industry

According to the U.S. Department of Labor, a record 4.5 million workers quit their jobs in March 2022—a trend that has continued through the summer. Paired with rising inflation costs, this so-called “Great Resignation” is straining the clinical trial industry like never before. Turnover for both patient-facing and operations staff has been on the rise, causing some trials to come to a screeching halt.  

Clinical trial software such as Devana Solutions PROPEL can help central research operations save time and money by improving workflows and streamlining pipeline management.  

Streamline Processes with Clinical Trial Software 

With high turnover comes frequent regulatory and staff updates, including updating logs, gathering new signatures, and amending databases. Designed specifically for the clinical trial industry, PROPEL provides technological support for various backend workflows, including data entry, reporting, admin support, enrollment, query resolutions, and communications. Say goodbye to duplicate data entry! 

PROPEL enables users to automate tasks and reminders to expedite study start-up and ensure that nothing is overlooked or forgotten as staffing situations change. Teams can also link multiple contacts, documents, and communications across each clinical trial to save time and improve performance visibility. For end-to-end operational excellence, PROPEL integrates with other mission-critical systems, such as your CTMS and Microsoft Outlook. Instead of hunting for lost communications caused by staff turnover, PROPEL creates threaded conversations and allows users to attach documents, link related calls, and even send emails and messages directly from within the platform. 

Utilizing PROPEL, operations professionals can query site capabilities based on therapeutic expertise, investigator and staff certifications, physical site facilities, and more. This enables teams to efficiently share protocols digitally and distribute trial opportunities and documentation to study teams without the need for external communications or cumbersome old databases, saving both time and money. In addition, PROPEL is entirely cloud-based, which makes it simple for remote and decentralized users to log in and execute. 

Specifically designed for efficiency, PROPEL enables teams impacted by turnover and decreased budgets to accomplish more with less. 

Devana Solutions 

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems. 

Let us show you in more detail what Better Data, Better Decisions, and Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs. 

Effectively Manage Decentralized Sites with Clinical Trial Software

Since the beginning of the COVID-19 pandemic, more and more organizations have been exploring the possibilities of decentralized clinical trials (DCTs). Decentralized trials have many benefits, including accelerated patient access, improved patient engagement and retention, and increased diversity. Unfortunately, these benefits also come with challenges such as reduced collaboration and limited data access.

Clinical trial software such as Devana Solutions PROPEL can help central research operations connect to decentralized site staff during study startup through trial completion, regardless of site location.

Increase Collaboration, Data-Sharing, and Visibility Across DCTs

Devana Solution’s cloud-based software seamlessly and securely connects central research sites, CROs, Sponsors, and decentralized sites, facilitating real-time collaboration and sharing of data. Our solutions allow research operations professionals to share protocols, contracts, budgets, and other supporting trial documentation with decentralized sites, speeding study startup and improving visibility across the trial’s network.

Forget managing cumbersome emails, phone calls, and lengthy meetings—central teams can communicate directly to sites within PROPEL, and all correspondence is logged for future reference. Sites can also update their key milestones via our LYNK interface, ensuring the central team is always aware of the status of the trial. Central research teams can even assign tasks to sites and view what has been completed and remains outstanding.

Instead of manually searching for opportunities or site-specific details, PROPEL allows users to query all sites, filter key data, and collate opportunities. Customizable dashboards and reports provide real-time visibility and help centralized and site-based decision-makers gain actionable insights. The Devana Solutions platform can connect every functional group in a network’s entire organization, from business development and regulatory to finance and leadership.

By leveraging the cloud to connect central teams with site-based clinicians and staff for real-time collaboration, PROPEL provides easy access and visibility to trial, site, user, and contact data across your network—helping to bridge data gaps, secure more trial opportunities, hit more targets, and win more awards.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Our platform bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems.

Let us show you in more detail what Better Data, Better Decisions, and Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Devana Solutions CEO Barry Lake on Note to File Podcast

Devana Solutions CEO Barry Lake recently sat down with Brad Hightower of the Note to File Podcast to discuss the current state of the industry and the importance of sites tracking their own metrics using clinical trial software like Devana Solutions.

Offering holistic trial analysis and a dynamic site and investigator database, Devana Solution’s enterprise software gives businesses the crucial support and data management they need to focus on their own business efforts and core competencies. We understand the unique challenges of the clinical trials industry and offer comprehensive solutions such as automated data evaluation and communication, freeing teams from repetitive tasks so they can focus on winning more study contracts.

For life-saving therapies and vaccines to reach patients more quickly, leading research organizations turn to Devana Solutions for cutting-edge cloud-based SaaS technology and services in the clinical trial industry.

Check out Barry’s episode of the Note to File Podcast here.

Note to File Podcast

Note to File is a podcast for clinical research sites, featuring interviews, best practices, and candid commentary from host Brad Hightower, founder of Hightower Clinical and clinical research professional. The podcast was born with the hope of providing a resource for research professionals to share their stories and serve as a source for practical advice for the clinical research community.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Improve Study Outcomes with Clinical Trial Software for CROs

The relationship between sponsors and contract research organizations (CROs) is strengthening as outsourcing becomes a clinical trial norm. It is important for the CRO to have a good working relationship with sites in order to ensure that the trial is successful, particularly in the study startup phase, as clinical trials are increasingly expensive and time-consuming endeavors.

Key factors that influence a good relationship and where clinical trial software can help are:

  • Targeted Site Selection
  • Digitized Feasibility
  • Enhanced Site Collaboration and Communication
  • Process and Performance Transparency

Targeted Site Selection

More complex protocols require more precise site selection. Devana’s PROPEL technology allows for CROs to perform automated queries during site selection to determine the right sites or investigators based on the requirements of the protocol. PROPEL allows CROs to store the site and investigator performance and capabilities data that can be managed and updated by the sites, in real-time, allowing for more accurate site selection. Sponsors can be confident that the sites selected by the CRO will be capable of meeting performance expectations, resulting in better study outcomes.

Digitized Feasibility

While feasibility questionnaires are certainly a critical piece to selecting the right sites for a trial, the entire process, as it is today, is a bit archaic. Devana is revolutionizing the feasibility process by allowing CROs to submit a digitized feasibility to the sites selected for each trial. Say goodbye to outdated PDFs and third-party websites. This digital feasibility will pre-populate information that typically remains the same, trial to trial, such as the site’s location and contact information, but allows for the CROs to receive new, trial-specific data such as subject population criteria. The sites can review their previously submitted data for accuracy and respond to any new inquiries, resulting in a speedier feasibility process and a lower cost for the Sponsor.

Enhanced Site Collaboration and Communication

In addition to improving the feasibility process, Devana took it a step further by creating a threaded communication feed between the sites and CROs within the PROPEL platform. If a Sponsor reaches out to a CRO about a trial in bid-defense, needing to quickly know the potential subject pool for a particular indication, the CRO can instantly push out a mass communication to the sites and gather their responses within the platform. No more cumbersome calls or emails to track. Just the same, if a CRO submits a site for a trial, the site can review the details and provide feedback to the CRO or ask questions related to the protocol. It’s a win-win for all involved, the site, the CRO and the Sponsor, since this connectivity allows for more efficient communication throughout the entire clinical trial process.

Process and Performance Transparency

Another important aspect of a good working relationship between Sponsors and CROs is process and performance transparency. The entire clinical trial process, from study startup through close-out, produces a lot of key data. By using PROPEL, CROs have real-time views into the trial, by site, to know exactly where the trial is at any given time. The ability to quickly obtain this data and provide to Sponsors is critical to the swift and successful execution of a trial and the ability to mitigate risk.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Boost Study Contract Wins in the Clinical Trial Industry

Is your clinical trial organization looking to boost study contract wins and shorten the sales cycle? Then you need to ensure you have the right tools in your tech stack. In the age of technology, there are many options available but one you must include is a trial startup software that synchronizes your communication and data for increased efficiency.

A quality trial startup technology solutions provider, like Devana Solutions, will understand the unique challenges of the industry and offer comprehensive solutions such as automated data evaluation and communication that frees the sales team from repetitive tasks so they can focus on winning the study contract.

Devana Solutions Saves Time and Shortens Sales Cycles

By eliminating repetitive tasks, Devana Solutions’ PROPEL platform is able to shorten the overall sales cycle. Put an end to the tedious work in spreadsheets or disparate systems, as PROPEL is able to automate sales processes, capture a complex chain of emails, and account for customized variations.

In addition, PROPEL allows for each cross-functional team to seamlessly communicate with one another and understand what stage the trial is in during the startup process. The best software will be easily accessible to every decision-maker across the trial management process.

How Trial Software Software Boosts Sales in the Clinical Trial Industry

Increased data means more informed decision-making. With a vibrant and dynamic site and investigator database, as well as up to date performance metrics, the sales team is able to focus their efforts to determine the best trial opportunities for their organization. Increased data streams allow the organization to predict how their business development strategies will affect their overall operations.

Choosing the Best Trial Startup Software for Your Clinical Trial Business

The best clinical trial software will be one that is designed with the unique challenges of the clinical trials industry in mind. Offering holistic trial analysis and a dynamic site and investigator database, Devana Solutions’ PROPEL enterprise software gives businesses the crucial support they need to focus their business efforts for much success.

Sign up for a free demo and learn what makes PROPEL the best in the industry.

Devana Solutions

Devana Solutions is an innovative cloud software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

2022 World Vaccine Congress: What to Expect

Devana Solutions executives are attending the 2022 World Vaccine Congress in Washington D.C., on April 18-21, 2022. Here’s what leaders in the biopharma industry can expect.The World Vaccine Congress, in existence for over two decades, has grown to become the largest and most established conference dedicated to vaccines, globally. The World Vaccine Congress 2022 will bring together thousands of industry experts across the entire vaccine landscape, with key sessions dedicated to the fight against COVID-19. Taking place April 18-21 at the flagship hotel, Marriott Marquis Washington, DC, the event will be one of the first opportunities to meet in person since the pandemic began to learn, share experiences and ground-breaking knowledge, and network with others who are working against COVID-19 and on other important vaccines.

“If there is anything that the last two years have taught this industry, it’s that the pandemic has certainly put the focus on the need for cutting-edge research to produce more and better vaccines,” Devana Solutions CEO and Co-Founder Barry Lake.

Inside Peek: 2022 World Vaccine Congress Washington

An event that prides itself on covering every subject across the entire vaccine value chain, here is what to expect if you are attending:

  • Visionary Presenters
  • Engaging Agenda
  • Networking Breaks
  • Vaccine Excellence Awards

Visionary Presenters

This year’s presenters are disruptors and visionary industry leaders from the biopharma industry. They are selected for their relevance, dynamism, and insight. Just a handful of speakers at the World Vaccine Congress include:

Engaging Agenda

From basic research to commercial manufacture, World Vaccine Congress covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress. If you are involved in vaccines or new to it because of the pandemic, World Vaccine Congress is the most important meeting you will be part of in 2022.

Here are some of the topics discussed each day:

April 18

  • Biodefense and preparedness
  • Maternal immunization
  • Vaccine Technology
  • Antimicrobial resistance
  • Antibodies in treating COVID and infectious diseases
  • HIV

April 19

  • Plenary Sessions
  • Interactive roundtable discussions
  • Evening drinks & ViE Awards Dinner

April 20 & 21

  • COVID, influenza and other respiratory diseases
  • Immune profiling
  • Cancer immunotherapy
  • One health and veterinary vaccines
  • Clinical trials and development
  • Manufacture
  • Safety
  • Market access
  • Supply & logistics
  • Newly infectious and chronic diseases

Networking

Being the first in-person World Vaccine Congress since 2020, networking is an essential part of the conference experience. You can find new opportunities to collaborate or meet other people in your field. With over 30 scheduled networking events, from coffee breaks to luncheons, there is ample opportunity to learn and network with colleagues across the industry.

Vaccine Excellence Awards

On Tuesday, April 19th, the World Vaccine Congress will be hosting the 15th Annual Vaccine Industry Excellence Awards Ceremony & Dinner. The Scientific Advisory Board members will help make the final decision in each category, and the winners will be announced at the dinner.

“Devana Solutions is proud to have supported many of the leading vaccine research site organizations that stepped up in a big way during the COVID pandemic, including hyperCORE International, Benchmark Research, Centricity Research, Javara Research, Velocity Clinical Research and Accel Research Sites. We wanted to be in Washington, D.C. to support many of these clients nominated for well-deserved Vaccine Excellence Awards,” said Lake.

Are you planning on attending the 2022 World Vaccine Congress Washington? We’d love to chat. Devana Solutions’ CEO and Co-founder Barry Lake and Director, Strategic Partnerships, Emily Hardy, will be attending the show in the nation’s capital and are available to discuss how technology can improve your clinical trial management process. Connect with Barry or Emily on LinkedIn or use the contact form at the bottom of the page to set something up before the big event!

Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.

1 2 3 4